DUSP9 (dual specificity phosphatase 9) is a cytoplasmic phosphatase that primarily functions to negatively regulate MAPK signaling pathways by dephosphorylating key kinases including ERK1/2, p38, JNK, and ASK1 1. The enzyme belongs to the threonine/tyrosine dual-specific phosphatase family and controls various MAPK pathway cascades through its phosphatase activity 1. DUSP9's mechanism involves direct protein interactions, as demonstrated by its binding to insulin receptor substrate 1 (IRS1) where it inhibits IRS1 phosphorylation at Tyr632, thereby impairing downstream insulin signaling 2. The protein is subject to post-translational regulation, with ubiquitination leading to its degradation 3. Disease relevance varies significantly by tissue context - DUSP9 is downregulated in colorectal cancer where it functions as a tumor suppressor by inhibiting proliferation, migration, and epithelial-mesenchymal transition 4, but is upregulated in head and neck squamous cell carcinoma where it promotes tumor progression 5. In metabolic diseases, DUSP9 contributes to insulin resistance in gestational diabetes mellitus and metabolic-associated steatohepatitis 26. These opposing roles highlight DUSP9's context-dependent functions as either a tumor suppressor or oncogene, making it a potential therapeutic target requiring tissue-specific approaches.